Dexamethasone for preventing lung disease in premature babies
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests whether a medicine called dexamethasone (a steroid) can help prevent a serious lung problem in very premature babies. It is for babies who still need a breathing machine after two weeks of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 24 and 30 weeks of pregnancy.
- Your baby has needed a breathing machine (ventilator) for at least 14 days since birth.
- Your baby is between 2 and 4 weeks old right now.
- Your baby needs a high level of oxygen and breathing support at this moment.
- Your baby has not received any other steroid medicines before joining.
- You (parent or guardian) must give written permission for your baby to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a steroid medicine called betamethasone shortly after birth can help extremely premature babies get off breathing support more safely and effectively. If your baby is very early and needs help breathing, this could lead to faster and safer recovery.
This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.
This trial tests if intravenous immunoglobulin (IVIG) can help prevent or treat bronchopulmonary dysplasia (BPD), a lung condition in premature babies. It is for very preterm infants born between 25 and 29 weeks who show early signs of BPD and are enrolled in the first day of life.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
This trial studies how well dexamethasone works and how it behaves in the body when given during preterm labor to help the baby’s lungs mature. You may be able to join if you’re pregnant between 24–36 weeks and are receiving the study treatment per their schedule.
Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.